Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Avanos Medical (AVNS – Research Report), Deciphera Pharmaceuticals (DCPH – Research Report) and Fulcrum Therapeutics (FULC – Research Report).
Avanos Medical (AVNS)
JMP Securities analyst David Turkaly reiterated a Hold rating on Avanos Medical today. The company’s shares closed last Wednesday at $24.44.
According to TipRanks.com, Turkaly is a 3-star analyst with an average return of
Currently, the analyst consensus on Avanos Medical is a Moderate Sell with an average price target of $26.50.
See Insiders’ Hot Stocks on TipRanks >>
Deciphera Pharmaceuticals (DCPH)
JMP Securities analyst Reni Benjamin reiterated a Buy rating on Deciphera Pharmaceuticals today and set a price target of $23.00. The company’s shares closed last Wednesday at $13.93.
According to TipRanks.com, Benjamin has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Deciphera Pharmaceuticals is a Moderate Buy with an average price target of $22.33.
Fulcrum Therapeutics (FULC)
In a report released today, Madhu Kumar from Goldman Sachs downgraded Fulcrum Therapeutics to Hold, with a price target of $3.00. The company’s shares closed last Wednesday at $2.93, close to its 52-week low of $2.25.
According to TipRanks.com, Kumar is a 5-star analyst with an average return of
Fulcrum Therapeutics has an analyst consensus of Hold, with a price target consensus of $8.13.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AVNS:
